MetaCap

Ultralife Corporation (ULBI)

NASDAQ: ULBIMiscellaneousIndustrial Machinery/ComponentsUSD

15.58-0.11 (-0.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ULBI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$259.63M
EPS (TTM)
-$0.17
52-week range
5.00 – 15.83
Day range
15.56 – 15.80
Volume / Avg
297.11K / 129.78K
Beta
—

52-week range

$5.00$15.83

ULBI stock today

Shares of Ultralife (ULBI) finished lower on Nov 20 at $15.58, a drop of 0.70% or $0.11 per share, versus the S&P 500's 3.70% decline. Volume was 2.3x the average at 297.11K shares, a sign of unusually heavy trading. At this level, ULBI sits near the top of its 52-week range of $5.00 to $15.83: 1.6% below the high, set on Nov 10, 2026 and 211.6% above the low.

ULBI is up 172.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 197.3%. Ultralife has posted a net loss over the last twelve months (EPS of -$0.17), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Ultralife

Company profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Industry
Industrial Machinery/Components
CEO
Mr. Michael E. Manna
Headquarters
Newark, NY
Employees
678
IPO year
1992

Financial highlights

Full financials

In fiscal 2025, Ultralife generated $191.2 million in revenue, up 16.2% from fiscal 2024, its 4th consecutive year of revenue growth. Ultralife reported a net loss of $5.9 million, compared with net income of $6.3 million a year earlier. Gross margin was 24.1% (down from 25.7%) and operating margin -3.1%.

Ultralife annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$191.16M$164.46M$158.64M$131.84M$98.27M
Growth+16.24%+3.66%+20.33%+34.17%-8.77%
Net income$-5.90M$6.31M$7.20M$-119.00K$-234.00K
EPS (diluted)$-35.00$38.00$0.44$0.05$0.05

Earnings

Earnings history
Last reported (Q3 2026)
Nov 6, 2026
EPS actual vs est.
$0.14 vs —

ULBI news

All ULBI news

Ultralife peers

Miscellaneous sector
ULBI peer companies
CompanyPrice% ChgMarket capCompare
ACUAcme United Corporation.66.17-1.46%$262.55Mvs ULBI
HLPHongli Group Inc. Class A3.36-2.89%$251.12Mvs ULBI
ENVXEnovix Corporation1.17-9.30%$248.60Mvs ULBI
MPTIM-tron Industries Inc.63.24-4.24%$274.80Mvs ULBI
CUBLionheart Holdings Class A10.98+0.09%$287.27Mvs ULBI
CHPTChargePoint Holdings Inc.8.72-9.45%$234.13Mvs ULBI
NNBRNN Inc.2.49-10.75%$233.42Mvs ULBI
TWINTwin Disc Incorporated21.21-6.07%$308.37Mvs ULBI

Ultralife stock FAQ

What is Ultralife's stock price today?

ULBI last traded at $15.58 as of Nov 20, 4:00 PM EST, down 0.70% on the day. Prices are delayed at least 15 minutes.

Who is Ultralife's CEO?

Mr. Michael E. Manna is the chief executive officer of Ultralife Corporation, which has about 678 employees.

What is the ULBI 52-week high?

The 52-week high for ULBI is $15.83 and the 52-week low is $5.00. The stock is currently 1.6% below its high.

Compare ULBI